JPM23: After rock climbing in biotech, Novartis' CMO is back to support hopeful hike...

cafead

Administrator
Staff member
  • cafead   Jan 12, 2023 at 10:42: AM
via Novartis' chief medical officer and global drug development president Shreeram Aradhye, M.D., is back after a muscle-building stint in biotech, jumping into 2023 laser-focused on five therapeutic areas and driven by the company’s goal of becoming a top U.S. drugmaker.

article source
 

<